3 Citations (Scopus)

Abstract

Peripheral arterial disease (PAD) is characterized by myofiber degeneration and loss of function in muscles of the lower limbs. Human enterovirus (HEV) infection has been implicated in the pathogenesis of a number of muscle diseases. However, its association with PAD has not been studied. In this study, we tested the hypothesis that infectious HEV is present in skeletal muscle of patients with PAD and is associated with severity of disease. Gastrocnemius biopsies from 37 patients with PAD and 14 controls were examined for the presence of HEV RNA, viral capsid protein, viral RNA copy number, and viral infectivity. HEV RNA was detected in 54% of the biopsies from patients with PAD but was not detected in muscle biopsies from control patients. This difference in prevalence among PAD and control patients was significant at P<0.001. Viral RNA copy numbers were increased significantly at the later stages of disease; Fontaine Stage IV (10(5.50) copies/mg muscle wet weight, at P<0.005) and Stage III (10(4.87) copies/mg, at P<0.010) compared to Stage II (10(2.50) copies/mg). Viral replication was confirmed by the presence of the negative-strand of viral RNA in all specimens positive for HEV RNA. Cultures of HeLa and human skeletal muscle cells treated with muscle homogenates showed HEV replication and the presence of HEV capsid protein. Our data identified infectious HEV in the gastrocnemius of PAD patients but not in controls. Viral copy number and prevalence of infection were higher in the later stages of disease. Our data point to the need for further studies to determine the contribution of HEV infection to the pathophysiology of PAD.

Original languageEnglish (US)
Pages (from-to)e000082
JournalJournal of the American Heart Association
Volume2
Issue number4
DOIs
StatePublished - Aug 2013

Fingerprint

Enterovirus
Peripheral Arterial Disease
Viral RNA
Muscles
Enterovirus Infections
Capsid Proteins
RNA
Biopsy
Skeletal Muscle
Viral Proteins
Muscle Cells
Lower Extremity
Weights and Measures

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Human enterovirus in the gastrocnemius of patients with peripheral arterial disease. / Kim, Julian K S; Zhu, Zhen; Casale, George P; Koutakis, Panagiotis; McComb, Rodney D; Swanson, Stanley; Thompson, Jonathan; Miserlis, Dimitrios; Johanning, Jason M; Haynatzki, Gleb; Pipinos, Iraklis I.

In: Journal of the American Heart Association, Vol. 2, No. 4, 08.2013, p. e000082.

Research output: Contribution to journalArticle

Kim, Julian K S ; Zhu, Zhen ; Casale, George P ; Koutakis, Panagiotis ; McComb, Rodney D ; Swanson, Stanley ; Thompson, Jonathan ; Miserlis, Dimitrios ; Johanning, Jason M ; Haynatzki, Gleb ; Pipinos, Iraklis I. / Human enterovirus in the gastrocnemius of patients with peripheral arterial disease. In: Journal of the American Heart Association. 2013 ; Vol. 2, No. 4. pp. e000082.
@article{aa31fd25b66a4d098ecfcfa16eb67623,
title = "Human enterovirus in the gastrocnemius of patients with peripheral arterial disease.",
abstract = "Peripheral arterial disease (PAD) is characterized by myofiber degeneration and loss of function in muscles of the lower limbs. Human enterovirus (HEV) infection has been implicated in the pathogenesis of a number of muscle diseases. However, its association with PAD has not been studied. In this study, we tested the hypothesis that infectious HEV is present in skeletal muscle of patients with PAD and is associated with severity of disease. Gastrocnemius biopsies from 37 patients with PAD and 14 controls were examined for the presence of HEV RNA, viral capsid protein, viral RNA copy number, and viral infectivity. HEV RNA was detected in 54{\%} of the biopsies from patients with PAD but was not detected in muscle biopsies from control patients. This difference in prevalence among PAD and control patients was significant at P<0.001. Viral RNA copy numbers were increased significantly at the later stages of disease; Fontaine Stage IV (10(5.50) copies/mg muscle wet weight, at P<0.005) and Stage III (10(4.87) copies/mg, at P<0.010) compared to Stage II (10(2.50) copies/mg). Viral replication was confirmed by the presence of the negative-strand of viral RNA in all specimens positive for HEV RNA. Cultures of HeLa and human skeletal muscle cells treated with muscle homogenates showed HEV replication and the presence of HEV capsid protein. Our data identified infectious HEV in the gastrocnemius of PAD patients but not in controls. Viral copy number and prevalence of infection were higher in the later stages of disease. Our data point to the need for further studies to determine the contribution of HEV infection to the pathophysiology of PAD.",
author = "Kim, {Julian K S} and Zhen Zhu and Casale, {George P} and Panagiotis Koutakis and McComb, {Rodney D} and Stanley Swanson and Jonathan Thompson and Dimitrios Miserlis and Johanning, {Jason M} and Gleb Haynatzki and Pipinos, {Iraklis I}",
year = "2013",
month = "8",
doi = "10.1161/JAHA.113.000082",
language = "English (US)",
volume = "2",
pages = "e000082",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Human enterovirus in the gastrocnemius of patients with peripheral arterial disease.

AU - Kim, Julian K S

AU - Zhu, Zhen

AU - Casale, George P

AU - Koutakis, Panagiotis

AU - McComb, Rodney D

AU - Swanson, Stanley

AU - Thompson, Jonathan

AU - Miserlis, Dimitrios

AU - Johanning, Jason M

AU - Haynatzki, Gleb

AU - Pipinos, Iraklis I

PY - 2013/8

Y1 - 2013/8

N2 - Peripheral arterial disease (PAD) is characterized by myofiber degeneration and loss of function in muscles of the lower limbs. Human enterovirus (HEV) infection has been implicated in the pathogenesis of a number of muscle diseases. However, its association with PAD has not been studied. In this study, we tested the hypothesis that infectious HEV is present in skeletal muscle of patients with PAD and is associated with severity of disease. Gastrocnemius biopsies from 37 patients with PAD and 14 controls were examined for the presence of HEV RNA, viral capsid protein, viral RNA copy number, and viral infectivity. HEV RNA was detected in 54% of the biopsies from patients with PAD but was not detected in muscle biopsies from control patients. This difference in prevalence among PAD and control patients was significant at P<0.001. Viral RNA copy numbers were increased significantly at the later stages of disease; Fontaine Stage IV (10(5.50) copies/mg muscle wet weight, at P<0.005) and Stage III (10(4.87) copies/mg, at P<0.010) compared to Stage II (10(2.50) copies/mg). Viral replication was confirmed by the presence of the negative-strand of viral RNA in all specimens positive for HEV RNA. Cultures of HeLa and human skeletal muscle cells treated with muscle homogenates showed HEV replication and the presence of HEV capsid protein. Our data identified infectious HEV in the gastrocnemius of PAD patients but not in controls. Viral copy number and prevalence of infection were higher in the later stages of disease. Our data point to the need for further studies to determine the contribution of HEV infection to the pathophysiology of PAD.

AB - Peripheral arterial disease (PAD) is characterized by myofiber degeneration and loss of function in muscles of the lower limbs. Human enterovirus (HEV) infection has been implicated in the pathogenesis of a number of muscle diseases. However, its association with PAD has not been studied. In this study, we tested the hypothesis that infectious HEV is present in skeletal muscle of patients with PAD and is associated with severity of disease. Gastrocnemius biopsies from 37 patients with PAD and 14 controls were examined for the presence of HEV RNA, viral capsid protein, viral RNA copy number, and viral infectivity. HEV RNA was detected in 54% of the biopsies from patients with PAD but was not detected in muscle biopsies from control patients. This difference in prevalence among PAD and control patients was significant at P<0.001. Viral RNA copy numbers were increased significantly at the later stages of disease; Fontaine Stage IV (10(5.50) copies/mg muscle wet weight, at P<0.005) and Stage III (10(4.87) copies/mg, at P<0.010) compared to Stage II (10(2.50) copies/mg). Viral replication was confirmed by the presence of the negative-strand of viral RNA in all specimens positive for HEV RNA. Cultures of HeLa and human skeletal muscle cells treated with muscle homogenates showed HEV replication and the presence of HEV capsid protein. Our data identified infectious HEV in the gastrocnemius of PAD patients but not in controls. Viral copy number and prevalence of infection were higher in the later stages of disease. Our data point to the need for further studies to determine the contribution of HEV infection to the pathophysiology of PAD.

UR - http://www.scopus.com/inward/record.url?scp=84899610011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899610011&partnerID=8YFLogxK

U2 - 10.1161/JAHA.113.000082

DO - 10.1161/JAHA.113.000082

M3 - Article

C2 - 23920231

AN - SCOPUS:84899610011

VL - 2

SP - e000082

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 4

ER -